Category: Congress Info

The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. The recent collection of oral presentations provides a comprehensive overview of the latest advancements in phage therapy and antimicrobial research. Oral Presentation Summaries and…

The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. Poster Summaries and Scientific Impacts 1. Development of Phage-based Tool with the Potential to Treat Antibiotic-Resistant Gonorrhea Magdalena Pelka, University of Warsaw, Poland The…

The Targeting Phage Therapy 2023 Best Short Oral Presentation award was discerned to: Bacteriophage-Antibiotic Combination Therapy Against Extensively Drug-Resistant Pseudomonas Aeruginosa Infection to Allow Liver Transplantation in a Toddler Brieuc Van Nieuwenhuyse, UC Louvain, Belgium Dr. Van Nieuwenhuyse explained to Targeting Phage Therapy: “My research focuses on bidirectional translational research, trying to analyze specific mechanisms…

The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA Ms. Burkardt was awarded for creating patient ready products in a remedy ready world. Spun-off from of one of the US’s only phage therapy cores, TAILOR Labs at Baylor College of Medicine, an ambitious new biotech…